Hatzoglou A - Search Results

1

TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.

Hatzoglou A, Roussel J, Bourgeade MF, Rogier E, Madry C, Inoue J, Devergne O, Tsapis A. Hatzoglou A, et al. J Immunol. 2000 Aug 1;165(3):1322-30. doi: 10.4049/jimmunol.165.3.1322. J Immunol. 2000. PMID: 10903733

2

The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.

Madry C, Laabi Y, Callebaut I, Roussel J, Hatzoglou A, Le Coniat M, Mornon JP, Berger R, Tsapis A. Madry C, et al. Among authors: hatzoglou a. Int Immunol. 1998 Nov;10(11):1693-702. doi: 10.1093/intimm/10.11.1693. Int Immunol. 1998. PMID: 9846698

3

Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.

Hatzoglou A, Deshayes F, Madry C, Laprée G, Castanas E, Tsapis A. Hatzoglou A, et al. BMC Mol Biol. 2002 Apr 18;3:4. doi: 10.1186/1471-2199-3-4. Epub 2002 Apr 18. BMC Mol Biol. 2002. PMID: 11960555 Free PMC article.

4

Activation of membrane estrogen receptors induce pro-survival kinases.

Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A, Castanas E. Alexaki VI, et al. Among authors: hatzoglou a. J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):97-110. doi: 10.1016/j.jsbmb.2005.08.017. Epub 2006 Jan 18. J Steroid Biochem Mol Biol. 2006. PMID: 16414261

5

Opioids modulate constitutive B-lymphocyte secretion.

Vassou D, Bakogeorgou E, Kampa M, Dimitriou H, Hatzoglou A, Castanas E. Vassou D, et al. Among authors: hatzoglou a. Int Immunopharmacol. 2008 May;8(5):634-44. doi: 10.1016/j.intimp.2008.01.002. Epub 2008 Jan 28. Int Immunopharmacol. 2008. PMID: 18387505

6

Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.

Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E. Hatzoglou A, et al. Among authors: hatzoglou c. Eur J Pharmacol. 1996 Aug 29;310(2-3):217-23. doi: 10.1016/0014-2999(96)00339-1. Eur J Pharmacol. 1996. PMID: 8884220

7

Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation.

Alexaki VI, Charalampopoulos I, Kampa M, Vassalou H, Theodoropoulos P, Stathopoulos EN, Hatzoglou A, Gravanis A, Castanas E. Alexaki VI, et al. Among authors: hatzoglou a. FASEB J. 2004 Oct;18(13):1594-6. doi: 10.1096/fj.04-1495fje. Epub 2004 Aug 2. FASEB J. 2004. PMID: 15289442

8

The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.

Kampa M, Papakonstanti EA, Alexaki VI, Hatzoglou A, Stournaras C, Castanas E. Kampa M, et al. Among authors: hatzoglou a. Exp Cell Res. 2004 Apr 1;294(2):434-45. doi: 10.1016/j.yexcr.2003.11.027. Exp Cell Res. 2004. PMID: 15023532

9

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.

Hatzoglou A, Bakogeorgou E, Castanas E. Hatzoglou A, et al. Eur J Pharmacol. 1996 Jan 25;296(2):199-207. doi: 10.1016/0014-2999(95)00703-2. Eur J Pharmacol. 1996. PMID: 8838457

10

Taxol inhibits opioid binding on T47D human breast cancer cells.

Bakogeorgou E, Hatzoglou A, Castanas E. Bakogeorgou E, et al. Among authors: hatzoglou a. Biochem Biophys Res Commun. 1997 Jun 9;235(1):201-4. doi: 10.1006/bbrc.1997.6688. Biochem Biophys Res Commun. 1997. PMID: 9196063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters